Mashhour Alqannas

King Khaled Hospital

Papers

1

Total Citations

2

H-Index

1

About

Dr. Mashhour Alqannas is a pioneering figure in surgical oncology, with a focused expertise in minimally invasive approaches to peritoneal surface malignancies. His major contribution lies in demonstrating the feasibility and safety of robotic and laparoscopic cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC)—a traditionally open, highly morbid procedure. Through a landmark multicenter study from Saudi Arabia, Dr. Alqannas provided critical evidence that these advanced techniques can achieve effective cytoreduction while reducing recovery times and complications for patients with peritoneal metastasis. This work, already cited in the surgical oncology community, positions him at the forefront of adopting robotic platforms for complex oncologic resections. His research directly addresses a poor-prognosis condition, offering hope for less invasive yet aggressive multimodal treatment. Dr. Alqannas’s contributions are shaping the future of peritoneal cancer management, bridging the gap between surgical innovation and improved patient outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Robotic and Laparoscopic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy, Multicenter Study From Saudi Arabia
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: King Khaled Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago